Cisplatinum‐induced renal salt wasting
- 1 January 1984
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 12 (2) , 150-154
- https://doi.org/10.1002/mpo.2950120219
Abstract
We report two patients who developed high urinary excretion of sodium chloride after receiving cisplatinum. One patient became symptomatically hyponatremic during intravenous administration of hypotonic fluid. The second patient developed orthostatic hypotension. Urine sodium and chloride concentrations exceeded 130 mmol/liter despite hyponatremia or volume depletion. There was no evidence of adrenal cortical impairment and no improvement with fludrocortisone. We propose that cisplatinum may inhibit solute transport by the thick ascending limb of Henle, causing clinically significant, previously unreported toxicity in patients receiving chronic cisplatinum antitumor therapy.Keywords
This publication has 7 references indexed in Scilit:
- The development of hyponatremia following combination chemotherapy for metastatic germ cell tumorsMedical and Pediatric Oncology, 1982
- Comparison of methods of evaluating nephrotoxicity of cis-platinumClinical Pharmacology & Therapeutics, 1980
- Toxicity of Cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydrationCancer, 1980
- Influence of the emetic reflex on vasopressin release in manKidney International, 1979
- Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving CisplatinAnnals of Internal Medicine, 1979
- Effects of aldosterone and potassium-sparing diuretics on electrical potential differences across the distal nephron.Journal of Clinical Investigation, 1977